Icon close

Close

People

Gillian Russell has over 15 years of experience counseling pharmaceutical, medical device, and cosmetic clients on a wide range of regulatory, compliance, and enforcement issues, with a focus on regulatory strategies and initiatives for the labeling, promotion and advertising of FDA-regulated products. Gillian frequently serves as legal counsel on Medical/Legal/Regulatory (MLR) committees and medical/scientific review committees and is known for providing practical and actionable advice and solutions. Gillian routinely advises on the full spectrum of promotional and non-promotional communications, including new product launches, direct-to-consumer promotion, social media, influencer marketing, and payer communications.

Gillian graduated from the University of Virginia School of Law, where she served as Executive Editor for the Virginia Environmental Law Journal and as a Hardy Cross Dillard fellow for legal research and writing. Gillian earned her B.A. magna cum laude from Princeton University, where she was a four-year member of the swimming team. 

Full Bio

Credentials

J.D., University of Virginia

B.A., Princeton University, magna cum laude

District of Columbia

New Jersey

Pennsylvania

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Icon close

Close

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Insights

Article · Source: Chambers and Partners

March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022

Article · Source: Chambers and Partners

March 19, 2021
Pharmaceutical Advertising

View all

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Icon close

Close

Matters

“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).

“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).

Insights

Article · Source: Chambers and Partners

March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022

Article · Source: Chambers and Partners

March 19, 2021
Pharmaceutical Advertising

View all

Credentials

J.D., University of Virginia

B.A., Princeton University, magna cum laude

District of Columbia

New Jersey

Pennsylvania